| Gianna Caldwell-duthely, LPN | |
|
1 Spring Garden Ter, Woburn, MA 01801-1836 | |
| (617) 999-2464 | |
| Not Available |
| Full Name | Gianna Caldwell-duthely |
|---|---|
| Gender | Female |
| Speciality | Licensed Practical Nurse |
| Location | 1 Spring Garden Ter, Woburn, Massachusetts |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205418407 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 164W00000X | Licensed Practical Nurse | LN98126 (Massachusetts) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Gianna Caldwell-duthely, LPN 1 Spring Garden Ter, Woburn, MA 01801-1836 Ph: (617) 999-2464 | Gianna Caldwell-duthely, LPN 1 Spring Garden Ter, Woburn, MA 01801-1836 Ph: (617) 999-2464 |
News Archive
BELLUS Health Inc. and Celtic Therapeutics announced today that a global confirmatory phase III clinical study was initiated on December 14, 2010 for KIACTA™ (eprodisate). KIACTA™ is a drug candidate being developed for the treatment of AA amyloidosis, a life-threatening orphan disease that occurs in patients with long-lasting inflammatory conditions, most commonly due to rheumatoid arthritis. The study is designed to confirm the safety and efficacy of KIACTA™ in preventing renal function decline in patients with AA amyloidosis.
Changes in how genes in the immune system function may result in age-related macular degeneration (AMD), the leading cause of visual impairment in older adults, based on preliminary research conducted by National Institutes of Health (NIH) investigators.
Cell Therapeutics, Inc. today announced that The NASDAQ Stock Market has granted CTI an additional 180 days to regain compliance with NASDAQ's $1.00 minimum bid price rule under NASDAQ Marketplace Rule 5550(a)(2)). Previously, on May 3, 2010, CTI was notified by NASDAQ that CTI did not meet the minimum bid price rule required for continued listing and was provided until November 1, 2010 to achieve compliance.
Fragile X syndrome (FXS) is the most common genetically inherited cause of intellectual disability in humans. New research shows how the hormone insulin - usually associated with diabetes - is involved in the daily activity patterns and cognitive deficits in the fruitfly model of FXS, according to a new study from the Perelman School of Medicine at the University of Pennsylvania published online this month in Molecular Psychiatry in advance of the print issue.
› Verified 5 days ago
Mr. Linno Cox Byomuhangi, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 317 Main St Apt 2, Woburn, MA 01801 Phone: 781-363-0108 | |
Melody J Gaeta, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 331 Montvale Ave, Suite 100, Woburn, MA 01801 Phone: 781-281-7250 Fax: 781-305-4189 | |
Jillian Carver, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 9 Forbes Rd, Woburn, MA 01801 Phone: 781-838-6757 | |
Charles Kelley, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 8 Tedesco Dr, Woburn, MA 01801 Phone: 781-690-1829 | |
Stephanie Theodore, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 9 Forbes Rd, Woburn, MA 01801 Phone: 781-838-6757 Fax: 781-939-6968 | |
Belyenda Doreen Namusaazi, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 44 Winter St, Woburn, MA 01801 Phone: 857-251-3274 |